Moonsoo earned his PhD in bioengineering at MIT, and is currently a Professor at Radiology at Weill Cornell Medicine. He founded a CAR T company, AffyImmune Therapeutics, which is actively testing novel CAR T products in humans. He founded Elate Medical with a goal to help clients to introduce their products to patients rapidly and cost effectively.
Dr. Van Besien is the Director of the Stem Cell Transplant Program, a Professor of Medicine at Weill Cornell Medicine and an attending physician at New York Presbyterian Hospital.
We have a network of GMP facilities at leading academic institutions and hospitals that provide time and cost-efficient service for early phase cell therapy products for our clients.
We have in-depth expertise in devleloping an automated, robust manufacturing process, and documentation for IND CMC.
We are leading experts in developing CAR T cells, virus-specific T cells, and other cellular products in providing clinical care and studies to treat patients with cancer and infectious diseases.
We are developing a 100% automated, walk-away operation at point-of-care device for manufacturing cell therapy drugs. This device is designed to be customizable for client specific manufacturing process.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.